Infographic: Half-dose photodynamic therapy versus high-density subthreshold micropulse laser treatment in patients with chronic central serous chorioretinopathy: the PLACE trial (2023)

First Author: Yusuf I
Attributed to:  Development of AAV gene therapy for blindness caused by cone-rod dystrophy funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41433-023-02395-1

PubMed Identifier: 37095275

Publication URI: http://europepmc.org/abstract/MED/37095275

Type: Journal Article/Review

Parent Publication: Eye